103859-81-0

Basic information

• Product Name: (3-METHOXY-4-PROPOXYPHENYL)METHANOL
• CAS NO: 103859-81-0
• Molecular Formula: C₁₁H₁₆O₃
• Molecular Weight: 196.25
• Mol File: 103859-81-0.mol

Chemical Properties

• Boiling Point: 308.2°Cat760mmHg
• Flash Point: 140.2°C
• Appearance: /
• Density: 1.064g/cm³
• Vapor Pressure: 0.000299mmHg at 25°C
• Refractive Index: 1.512
• CAS DataBase Reference: (3-METHOXY-4-PROPOXYPHENYL)METHANOL(CAS DataBase Reference)
• NIST Chemistry Reference: (3-METHOXY-4-PROPOXYPHENYL)METHANOL(103859-81-0)
• EPA Substance Registry System: (3-METHOXY-4-PROPOXYPHENYL)METHANOL(103859-81-0)

Safety Data

• Hazardous Substances Data: 103859-81-0(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
(3-Methoxy-4-propoxyphenyl)methanol is used as an intermediate in the synthesis of various pharmaceuticals and organic compounds. Its potential antioxidant and anti-inflammatory properties make it a promising candidate for medical applications.
Used in Fragrance and Flavoring Industry:
(3-Methoxy-4-propoxyphenyl)methanol is used as a component in the production of fragrances and flavorings, adding unique scents and tastes to various products.

InChI:InChI=1/C11H16O3/c1-3-6-14-10-5-4-9(8-12)7-11(10)13-2/h4-5,7,12H,3,6,8H2,1-2H3

Upstream product

• 57695-98-4 3-methoxy-4-n-propoxybenzaldehyde 
• 121-33-5 vanillin 
• 86534-11-4 3-methoxy-4-(2-propenyloxy) benzenemethanol 
• 498-00-0 4-hydroxymethyl-2-methoxyphenol 
• 106-94-5 propyl bromide 

Downstream Products

• 861069-39-8 (3-methoxy-4-propoxy-phenyl)-acetonitrile 
• 23918-27-6 (3-methoxy-4-propoxy-phenyl)-acetic acid 
• 261359-02-8 4-(propyloxy)-3-methoxybenzyl bromide 
• 1335128-35-2 4-((4-chlorophenyl)(hydroxyl)methyl)-1-(3-methoxy-4-propoxybenzyl)-1H-1,2,3-triazole 
• 1335128-31-8 4-(azidomethyl)-2-methoxy-1-propoxybenzene 

Relevant articles and documents

Self-Assembly and Host-Guest Interactions of Pd3L2Metallo-cryptophanes with Photoisomerizable Ligands

New photoswitchable pyridyl-azo-phenyl-decorated tripodal host ligands (Laz) that belong to the cyclotriveratrylene family have been synthesized, and their photoswitching behavior and crystal structures determined. The latter includes a remarkable 7-fold

Guanidine catalyzed aerobic reduction: A selective aerobic hydrogenation of olefins using aqueous hydrazine

An efficient aerobic reduction of olefins, internal as well as terminal, is developed using guanidine as an organocatalyst. A remarkable chemoselectivity in reduction has been demonstrated in the presence of a variety of functional groups and protective groups and a selective reduction of a terminal olefin in the presence of an internal olefin is revealed.

Synthesis and biological evaluation of isosteric analogs of mandipropamid for the control of oomycete pathogens

A series of isosteric analogs of mandipropamid were designed and synthesized via 'click chemistry'. The amide bond of mandipropamid was substituted by a 1,2,3-triazole functional group. The bioassay results have indicated that some of the title compounds exhibited moderate fungicidal activity against Pseudoperonospora cubensis, and the activity has been systematically studied as a function of molecular structure. The low activity of the mandipropamid analog that contains a lipid chain is likely due to the presence of a weak hydrogen bond donor in the 1,2,3-triazole. Furthermore, we have performed the molecular modeling and found that N-methylamide could be more effective than amide as the surrogates to 1,2,3-triazole, which ultimately leads to a longer distance (1.1A longer) between the two substitutes in the 1,4-disubstituted 1,2,3-triazole compound.

Substituted γ-phenyl-Δ-lactams and uses related thereto

γ-Phenyl-substituted Δ-lactams are disclosed. They may be formulated into pharmaceutical compositions, and/or used in the treatment or prevention of inflammation or other conditions or disease states.

Substituted gamma-phenyl-delta-lactams and uses related thereto

gamma-Phenyl-substituted Delta-lactams are disclosed. They may be formulated into pharmaceutical compositions, and/or used in the treatment or prevention of inflammation or other conditions or disease states.

Substituted γ-phenyl-Δ-lactones and analogs thereof and uses related thereto

γ-Phenyl-substituted Δ-lactones and analogs thereof, including lactams, are disclosed. They may be formulated into pharmaceutical compositions, and/or used in the treatment or prevention of inflammation or other conditions or disease states.